These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30529062)

  • 21. The challenge of paediatric efavirenz dosing: implications and way forward for the sub-Saharan Africa.
    Mukonzo JK
    AIDS; 2014 Aug; 28(13):1855-7. PubMed ID: 25259700
    [No Abstract]   [Full Text] [Related]  

  • 22. Are We Giving Optimal Dose of Efavirenz?
    Yunihastuti E
    Acta Med Indones; 2016 Jan; 48(1):1-2. PubMed ID: 27241537
    [No Abstract]   [Full Text] [Related]  

  • 23. The Rise and Fall of Efavirenz.
    Cluck D; Lewis P; Durham SH; Hester EK
    J Int Assoc Provid AIDS Care; 2016 May; 15(3):181-3. PubMed ID: 26858315
    [No Abstract]   [Full Text] [Related]  

  • 24. Severe efavirenz-induced vacuolar axonopathy complicated by fatal aspiration pneumonia.
    Kenyon C; Mfolozi S; Croxford R; Colebunders R; Cohen K
    Br J Clin Pharmacol; 2012 Dec; 74(6):1070-2. PubMed ID: 22509819
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.
    Muñoz-Moreno JA; Fumaz CR; Ferrer MJ; González-García M; Moltó J; Negredo E; Clotet B
    AIDS Rev; 2009; 11(2):103-9. PubMed ID: 19529750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switching from efavirenz to nevirapine in children: 1-week dose escalation strategy.
    Udomphanit T; Lumbiganon P; Rattanamanee S; Harnlakorn P; Sopharak C; Sringam J; Anutchatchaval S; Tharnprisan P; Kosalaraksa P
    AIDS Res Hum Retroviruses; 2014 Aug; 30(8):727-9. PubMed ID: 24921980
    [No Abstract]   [Full Text] [Related]  

  • 27. New package inserts for efavirenz and T-20.
    AIDS Clin Care; 2007 Mar; 19(3):24. PubMed ID: 17595717
    [No Abstract]   [Full Text] [Related]  

  • 28. A systematic review of the psychiatric side-effects of efavirenz.
    Kenedi CA; Goforth HW
    AIDS Behav; 2011 Nov; 15(8):1803-18. PubMed ID: 21484283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early ritonavir-induced maculopapular eruption.
    Bachmeyer C; Blum L; Cordier F; Launay E; Danne O; Aractingi S; Mougeot-Martin M
    Dermatology; 1997; 195(3):301-2. PubMed ID: 9407188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population.
    Nelson M; Stellbrink HJ; Podzamczer D; Banhegyi D; Gazzard B; Hill A; van Delft Y; Vingerhoets J; Stark T; Marks S
    AIDS; 2011 Jan; 25(3):335-40. PubMed ID: 21150563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeat episode of late-onset psychosis associated with efavirenz.
    Basterreche N; Arrúe A; Arnaiz A; Olivas O; Zumárraga M
    Actas Esp Psiquiatr; 2020 Jul; 48(4):181-90. PubMed ID: 32920783
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe reaction to emtricitabine and lamiduvine: evidence of cross-reactivity.
    Suárez-Lorenzo I; Castillo-Sainz R; Cárden-Santana MA; Carrillo-Díaz T
    Contact Dermatitis; 2016 Apr; 74(4):253-4. PubMed ID: 26948418
    [No Abstract]   [Full Text] [Related]  

  • 33. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.
    Ford N; Calmy A; Mofenson L
    AIDS; 2011 Nov; 25(18):2301-4. PubMed ID: 21918421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications.
    Gaida R; Truter I; Grobler C; Kotze T; Godman B
    Expert Rev Anti Infect Ther; 2016; 14(4):377-88. PubMed ID: 26900637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of concomitant use of montelukast and efavirenz on neuropsychiatric adverse events.
    Ibarra-Barrueta O; Palacios-Zabalza I; Mora-Atorrasagasti O; Mayo-Suarez J
    Ann Pharmacother; 2014 Jan; 48(1):145-8. PubMed ID: 24259633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute renal failure.
    Angel-Moreno-Maroto A; Suárez-Castellano L; Hernández-Cabrera M; Pérez-Arellano JL
    J Infect; 2006 Feb; 52(2):e39-40. PubMed ID: 15996743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser.
    Elsharkawy AM; Schwab U; McCarron B; Burt AD; Daly AK; Hudson M; Masson S
    J Clin Virol; 2013 Sep; 58(1):331-3. PubMed ID: 23763943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adverse cutaneous reactions to antimicrobials in patients with human immunodeficiency virus infection.
    Miller DD; Warshaw EM
    Dermatitis; 2007 Mar; 18(1):8-25. PubMed ID: 17303040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral efficacy, tolerability and pharmacokinetics of efavirenz in an unselected cohort of HIV-infected children.
    Wintergerst U; Hoffmann F; Jansson A; Notheis G; Huss K; Kurowski M; Burger D
    J Antimicrob Chemother; 2008 Jun; 61(6):1336-9. PubMed ID: 18343800
    [TBL] [